- Major factors influencing the growth of the market.
- Leading players & Top Segments.
- Geographic Overview.
Market growth influenced due to following factors-
- Growing geriatric population.
- Increasing number of surgical procedures.
- Rising awareness programs globally.
Global market size-
According to research report the surgical drains market is expected to reach $2.18 Billion by 2022, growing at a CAGR of 3.7%.
The surgical drains market is highly competitive with several big and small players. Prominent players in this market include B. Braun (Germany), Cardinal Health (US), ConvaTec (UK), C.R. Bard (US), Redax (Italy), Ethicon (US), Stryker (US), Romsons (India), Medtronic (Ireland), Medline Industries (US), Cook Medical (US), Poly Medicure (India), Zimmer Biomet (Indiana), Global Medikit (India), Degania Silicone (Israel), Aspen Surgical (US), National Surgical (Australia), Axiom Medical (US), Péters Surgical (France), Ningbo Luke medical China), Goharshafa (Iran), ARMSTRONG MEDICAL (UK), Angiplast (India), CHIMED (Italy), and pfm medical (Germany).
Top Market Segments-
By applications, the wound drainage market is segmented into general surgery, cardiac and thoracic surgery, orthopedic surgery, obstetrics/gynecology surgery, and other surgeries.
Based on product, the surgical drains market is segmented into accessories and surgical drainage systems. In 2017, the accessories segment is expected to account for the largest share of the wound drainage market.
For Details, Download PDF Brochure
Geographic Overview -
In 2017, North America is expected to dominate the market followed by Europe. The large share of this geographical segment is attributed to factors such as increasing incidence of chronic wounds and surgical site infections, growing number of surgical procedures, rising geriatric population, and higher adoption and awareness of advanced surgical and wound care products.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.